Pages that link to "Q50921002"
Jump to navigation
Jump to search
The following pages link to Therapeutic option for managing lung injury induced by infrarenal aortic cross-clamping. (Q50921002):
Displaying 8 items.
- Attenuation of skeletal muscle and renal injury to the lower limb following ischemia-reperfusion using mPTP inhibitor NIM-811 (Q28540094) (← links)
- The significance and mechanism of propofol on treatment of ischemia reperfusion induced lung injury in rats (Q35215377) (← links)
- Pentoxifylline inhibits pulmonary inflammation induced by infrarenal aorticcross-clamping dependent of adenosine receptor A2A (Q36964138) (← links)
- Is adalimumab protective in ischemia-reperfusion injury in lung? (Q38600744) (← links)
- Remote effects of lower limb ischemia-reperfusion: impaired lung, unchanged liver, and stimulated kidney oxidative capacities (Q41950085) (← links)
- The influence of allopurinol and post-conditioning on lung injuries induced by lower-limb ischemia and reperfusion in Wistar rats (Q50093148) (← links)
- Ischemic preconditioning attenuates acute lung injury after partial liver transplantation. (Q55039365) (← links)
- Effect of Ischemic Postconditioning and Atorvastatin in the Prevention of Remote Lung Reperfusion Injury. (Q55079816) (← links)